Fenfluramin

Generic name
Fenfluramin
Brand name
ATC Code
N03AX26
Compare …

Fenfluramin

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Add-on therapy in Dravet syndrome, combined WITH stiripentol
  • Oral
    • 2 years up to 18 years
      • Initial dose: 0.2 mg/kg/day in 2 doses.
      • Maintenance dose: Increase dose based on effect after 4-7 days to 0.4 mg/kg/day in 2 doses. Max: 17 mg/day.
    • 2 years up to 18 years
      • Initial dose: 0.2 mg/kg/day in 2 doses.
      • Maintenance dose: Increase dose based on effect after 4-7 days to 0.4 mg/kg/day in 2 doses. Max: 17 mg/day.
Add-on treatment in Lennox-Gastaut
  • Oral
    • ≥ 2 years

      • Start: 0,2 mg/kg/day in 2 doses
        Day 7-14: 0,4 mg/kg/day in 2 doses
        Day 14 onwards: 0,7 mg/kg/day in 2 doses, max.  26 mg/day

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions

No information available on specific warnings and precautions in children.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIEPILEPTICS

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Barbiturates and derivatives
N03AA02
N03AA03
Hydantoin derivatives
N03AB02
Succinimide derivatives
N03AD01
Benzodiazepine derivatives
N03AE01
Carboxamide derivatives
N03AF01
N03AF02
N03AF03
Fatty acid derivatives
N03AG01
N03AG04
Other antiepileptics
N03AX23
N03AX24
N03AX10
N03AX18
N03AX09
N03AX14
N03AX22
N03AX16
N03AX17
N03AX03
N03AX11
N03AX15

Reference

  1. Zogenix ROI Limited, SmPC Fintepla 2,2 mg/ml Oral solution (EU/1/20/1491/001) Rev 8, 27-03-2024, www.geneessmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose